Company profile
Innunity Therapeutics
Developing first-in-class therapeutics by targeting key drivers of innate immunity
- Industry
- Biotechnology Research
- Employees
- 2
- Headquarters
- Zürich
- Office locations
- 1
Innunity Therapeutics company summary
Innunity Therapeutics is a company in the Biotechnology Research industry, headquartered in Zürich. On LinkedIn the company has around 2 employees.
What technology does Innunity Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Innunity Therapeutics
Innunity is a preclinical biotech with a focus on innate-immune-driven autoinflammatory disorders. By mapping emerging discoveries in innate immune biology to disease pathomechanisms, the company identifies novel targets and develops first-in-class therapeutics for conditions with severe patient burden. Innunity's lead program is INNU-1, a small molecule CLR pathway inhibitor addressing progressive multiple sclerosis.
Where is Innunity Therapeutics located?
Innunity Therapeutics lists 1 location.
Compare companies similar to Innunity Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Innunity Therapeutics innunitytx.com | Biotechnology Research | 2 | - | Zürich |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Innunity Therapeutics
What does Innunity Therapeutics do?
Innunity is a preclinical biotech with a focus on innate-immune-driven autoinflammatory disorders. By mapping emerging discoveries in innate immune biology to disease pathomechanisms, the company identifies novel targets and develops first-in-class therapeutics for conditions with severe patient burden. Innunity's lead program is INNU-1, a small molecule CLR pathway inhibitor addressing progressive multiple sclerosis.
How many employees does Innunity Therapeutics have?
Innunity Therapeutics has around 2 employees on LinkedIn.
Where is Innunity Therapeutics headquartered?
Innunity Therapeutics is headquartered in Zürich.
Build a lead list from companies like Innunity Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.